pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

49 catalysts · 21 approval · 9 device 510k · 9 device recall · 7 device pma · 3 grant

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-06×to 2026-01-06×clear all
type
  • approval21
  • device 510k9
  • device recall9
  • device pma7
  • grant3
therapy area

no tagged catalysts yet

Week of Jan 5, 2026

49
›Jan 6, 2026approval217d agoOLOPATADINE HYDROCHLORIDE — FDA approvalPataday

Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Pataday →fda approvals ↗
›Jan 6, 2026approval217d agoCIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN) — FDA approvalBedford Laboratories

Sponsor: UPSHER SMITH LABS. Form: SUSPENSION/DROPS. Route: OTIC

full page →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

Sponsor: SANALUZ. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jan 6, 2026approval217d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →olanzapine ODT →fda approvals ↗
›Jan 6, 2026approval217d agoMECLIZINE HYDROCHLORIDE — FDA approvalMECLIZINE HYDROCHLORIDE

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →MECLIZINE HYDROCHLORIDE →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Jan 6, 2026approval217d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Jan 6, 2026approval217d agoAMONDYS 45 (CASIMERSEN) — FDA approvalcasimersen

Sponsor: SAREPTA THERAPS INC. Form: SOLUTION. Route: INTRAVENOUS

full page →casimersen →fda approvals ↗
›Jan 6, 2026approval217d agoBORTEZOMIB — FDA approvalBortezomib Pfizer

Sponsor: GLAND. Form: POWDER. Route: INTRAVENOUS, SUBCUTANEOUS

full page →Bortezomib Pfizer →fda approvals ↗
›Jan 6, 2026approval217d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION

full page →ROCURONIUM BROMIDE →fda approvals ↗
›Jan 6, 2026device 510k217d agoAbanza Tecnomed S.L — QuadLock™ Fixation System (510k cleared)

Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoHh Global Technology, Inc. — Pen Needle (510k cleared)GSI TECHNOLOGY INC

Product code: FMI. Advisory committee: General Hospital. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoMaterialise NV — Materialise TKA Guide System (510k cleared)MATERIALISE NV

Product code: JWH. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoVesalio, Inc. — V-DAC Catheter (510k cleared)

Product code: QJP. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoEl Global Trade, Ltd. — Sensilift Pro (ST300XXYYZZZ) (510k cleared)

Product code: PAY. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoCarlsmed, Inc. — aprevo® cervical interbody system (510k cleared)CARLSMED, INC.

Product code: ODP. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoCrossroads Extremity Systems — TRILEAP Plating System (510k cleared)

Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoShanghai Medconn Medical Technology Co., Ltd. — Medconn 8K Glycated Hemoglobin Test System (510k cleared)NewBay Medical Technology Co Ltd

Product code: PDJ. Advisory committee: Clinical Chemistry. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device 510k217d agoInnaccel Technologies Private Limited — Saans (F4-01-00-000-000) (510k cleared)

Product code: SGR. Advisory committee: Anesthesiology. Type: Traditional

full page →fda device 510k ↗
›Jan 6, 2026device pma217d agoKardium, Inc. — Globe® Pulsed Field System (PMA supplement)Kardigan Inc

Supplement type: 30-Day Notice. Product code: QZI. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoVentana Medical Systems, Inc. (Roche Tissue Diagnostics) — VENTANA anti-MSH6 (SP93) Antibody (PMA supplement)

Supplement type: 30-Day Notice. Product code: QNH. Advisory committee: PA. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoVentana Medical Systems — VENTANA anti-MSH6 (SP93) Antibody (PMA supplement)

Supplement type: 30-Day Notice. Product code: QNH. Advisory committee: PA. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoAbbott Molecular, Inc. — Alinity m HR HPV (PMA supplement)

Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoSaluda Medical Pty, Ltd. — Saluda Medical Evoke SCS System (PMA supplement)

Supplement type: Normal 180 Day Track No User Fee. Product code: LGW. Advisory committee: NE. Decision: APPR

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoCordis US Corporation — EXOSEAL® Vascular Closure Device (PMA supplement)

Supplement type: 30-Day Notice. Product code: MGB. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device pma217d agoExact Sciences Corporation — Stool DNA (sDNA) Test, Cologuard Plus™ (PMA supplement)

Supplement type: 30-Day Notice. Product code: PHP. Advisory committee: PA. Decision: OK30

full page →fda device pma ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRIMSAFLEX M100 SET, Product Code 106697; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX ST100 SET US, Product Code 107636US; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

OXIRIS SET, Product Code 112016; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX M150 SET, Product Code 109990; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX TPE2000 SET, Product Code 114093; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX HF1000 SET, Product Code 107140; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX ST150 SET US, Product Code 107640US; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoStraumann USA LLC device recall (Cls III)

WB Impression Post Closed Tray incl. guide screw, L 13mm, TAN/POM — Reason: The mix up of the impression caps provided in the package. The provided impression caps are magenta instead of brown. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026device recall217d agoVANTIVE US HEALTHCARE LLC device recall (Cls II)

PRISMAFLEX HF1000 SET, Product Code 107142; Dialyzer, High Permeability With Or Without Sealed Dialysate System — Reason: There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit. — Status: Ongoing

full page →fda device recalls ↗
›Jan 6, 2026grant217d agoUNIVERSITY OF WASHINGTON — Real-time imaging of opioid neuromodulation with novel genetically encoded fl...University of Washington

DA grant. $49,538. PI: Lily Torp

full page →nih reporter ↗
›Jan 6, 2026grant217d agoOREGON HEALTH & SCIENCE UNIVERSITY — Metabolic coupling of oligodendroglia and endothelial cells through cell-spec...

NS grant. $74,632. PI: THADDEUS KUNKEL

full page →nih reporter ↗
›Jan 6, 2026grant217d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Polarity dysregulation in Alzheimer’s disease

NS grant. $50,000. PI: Huaye Zhang

full page →nih reporter ↗
$AMRX17.88-1.43%
$CARL
$MTLS6.5600-1.06%
$IGC0.2670+0.41%
$AMRX17.88-1.43%
$AMRX17.88-1.43%
$GSIT
$AMRX17.88-1.43%
$SRPT17.18+2.38%